The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Eosinophilic pneumonia (pulmonary infiltrates and eosinophilia)
Publications
A Case of Acute Eosinophilic Pneumonia Associated With Non-steroidal Anti-inflammatory Drugs.
Cureus 2024 Jan;16;e52159 — 2024 Jan
Eosinophilic pneumonia induced by non-steroidal anti-inflammatory drugs: An underestimated risk.
Therapie 2018 Dec;73;473-482 — 2018 Dec — 473-482
[Fever, pneumonia and eosinophilia].
Praxis 2007 Oct 03;96;1543-7 — 2007 Oct 03 — 1543-7
Pulmonary drug toxicity: radiologic and pathologic manifestations.
Radiographics : a review publication of the Radiological Society of North America, Inc 2000 Sep-Oct;20;1245-59 — 2000 Sep-Oct — 1245-59
Piroxicam induced pulmonary infiltrates and eosinophilia.
The Journal of rheumatology 1994 Aug;21;1573-7 — 1994 Aug — 1573-7
Nonsteroidal anti-inflammatory drug-associated pulmonary infiltrates with eosinophilia. Review of the literature and Food and Drug Administration Adverse Drug Reaction reports.
Archives of internal medicine 1992 Jul;152;1521-4 — 1992 Jul — 1521-4